The USA-India Chamber of Commerce mission is to provide a pro-active & professional platform for high ranking policy makers, senior business executives, academicians, and investors in the United States and India to network, facilitate and promote trade, investments & economic cooperation. USAIC’s four point agenda is: Trade, Investment, Policy and Advocacy.
2011
Leaders speak at US-India BioPharma & Healthcare Summit 2011
CXOs from the global biopharma shared the dais with their Indian counterparts in a frank sharing of concerns and suggested
solutions focussed on how India can align more closely with their agendas for a win-win situation. Viveka Roychowdhury reports Express Pharma News » View Pdf
Indian bio-pharma R&D spending could grow to $25 bn by 2025 The Economic Times News » View Pdf
India And U.S. Pharma Companies Meet To Discuss Evolving Partnership Models PharmAsia News » View Pdf
India Attracting More Investments in BioPharma R&D but Still Lacks Recognition as InnovationPartner, Says Study Fierce Biotech News » View Pdf
R&D spending in bio-pharma sector could grow to $25 b by 2025: BCG report Business Line News » View Pdf
US-India biopharma, healthcare meet to begin tomorrow Business Line News » View Pdf
Indian bio-pharma R&D spending could grow to $25 bn Express India News » View Pdf
Indian bio-pharma R&D spending could grow to $25bn by 2025 Money Control News » View Pdf
Partnering with India Pharma Tech Talk News » View Pdf
India Attracting More Investments in BioPharma R&D but Still Lacks Recognition asInnovation Partner, Says Study by The Boston Consulting Group PharmAsia News » View Pdf
Sneak Preview: BCG Study Predicts Strong R&D Focus In India; Big Pharma May Leverage India For "Niche Busters" And Stem Cells PharmAsia News » View Pdf
US-India BioPharma & Healthcare Summit to highlight India's potential to become a biopharma innovation hub Express Pharma » View Pdf
USAIC Indo-US Summit set to roll BioSpectrum » View Pdf
Budget pragmatic, growth-oriented: USAIC BusinessLine » View Pdf
India Budget is pragmatic, growth-oriented: US-India chamber
"Increase in healthcare and infrastructure expenditure is a positive step. We hope a serious attempt is made in the coming years to promote research and development in BioPharma," said Karun Rishi, the president of the USA-India Chamber of Commerce (USAIC). Deccan Herald » View Pdf Yahoo News » View Pdf Business Today » View Pdf MSN News » View Pdf
BioSpectrum honors biotech excellence
The BioSpectrum awardees were unanimously chosen by the 8th BioSpectrum Awards Jury headed by Mr Hari S Bhartia, co-chairman and MD, Jubilant Life Sciences. The award ceremony took place at Hotel Leela Palace in Bangalore. There were two categories of awards. Jury Awards – selected by the jury and Company Awards given on the basis of the BioSpectrum-ABLE annual industry survey the results of which are published in the June & July (2010) issues of BioSpectrum. BioSpectrum» View Pdf
International Summit Will Explore India's Potential as a Hub of Innovation and Partnerships in Biopharma
Conference in Cambridge, Mass. -- Organized by the USA-India Chamber of Commerce and Supported by The Boston Consulting Group -- Will Focus on Overcoming Barriers to Increased Collaboration Between Global and Local Companies The Boston Globe » View Pdf
International Summit Will Explore India's Potential as a Hub of Innovation and Partnerships in Biopharma
BOSTON, MA, Mar 02 (MARKET WIRE) -- The pressures bearing down on the global biopharmaceutical industry are forcing more companies to seek out new partners for collaboration and innovation. India, with its vast pool of R&D resources and capabilities, along with its growing demand for biopharma products, presents very attractive opportunities... Reuters » View Pdf Money Watch.com » View Pdf Morningstar » View Pdf
2010
Aspirations for collaboration can be bigger and bolder in US-India Biopharma & Healthcare Summit 2010
The Summit focussed on the need for greater and more transparent collaborations, and the perils of spending more money
protecting early-stage intellectual property (IP) than on early-stage research ExpressPharma» View Pdf
Pre-Competitive Collaboration Would Help Pharmaceutical Productivity Crisis – If Lawyers Could Get Out Of The Way
CAMBRIDGE, Mass. – Greater R&D collaboration was the theme of the day at the star-studded U.S.-India
Chamber of Commerce biopharma and healthcare summit..... PharmAsia News» View Pdf
New Approaches To Innovation Needed To Reach Globe’s Poor At The “Bottom
Of The Pyramid” – And To Fend Off Emerging Competitors Around The World
CAMBRIDGE, Mass. - Life science companies looking to provide healthcare solutions to the poorer,
“bottom of the pyramid” - a population reaching more than 600 million people in India alone - should focus
on business model innovation as much as on innovative products,.... PharmAsia News» View Pdf
USAIC to host annual US-India BioPharma & Healthcare Summit in USA
The USA-India Chamber of Commerce (USAIC), a bilateral Chamber of Commerce aimed at promoting and facilitating tradeand investment between the US and India is organising its annual US-India BioPharma & Healthcare Summit on May 6th, at Hyatt Regency Cambridge, Massachusetts, USA.... ExpressPharma» View Pdf
Indian Healthcare poised to take off: USAIC Report
Washington Bullish on the Indo-US BioPharma trends, the US-India Chamber of Commerce (USAIC) in its latest positionpaper has said Indian health care sector ispoised to take off along with the economy.... Express India» View Pdf
Indian healthcare poised to take off: USAIC report
Bullish on the Indo-US Bio Pharma trends, the US-India Chamber of Commerce (USAIC) in its latest position paper has said Indian healthcare sector is poised to take off along with the economy... Yahoo News» View Pdf
Leading US-India firms to attend Bio-Pharma summit
Reflecting the emergence of India as a top global destination for research and development in the bio-pharma sector,leading industry leaders, investors, academicians and policy makers would attend a day-long US-India Bio-Pharma and Healthcare Summit in Boston in May... BusinessStandard» View Pdf
US cos to attend bio-pharma summit
WASHINGTON: Reflecting the emergence of India as a top global destination for research anddevelopment in the bio-pharma sector, leading industry leaders, investors, academicians andpolicy makers would attend a day-long US-India Bio-Pharma and Healthcare Summit in Boston in May.... BusinessLine» View Pdf
US-India BioPharma and Healthcare Summit aims at big tie-ups
GhoshBoston, MA: US-India BioPharma and Healthcare Summit 2010 organized by the USA-India Chamber of Commerce here on July 26,
attracted over 350 senior bio-pharma executives, investors and academic leaders..... IndiaTribune» View Pdf
NEW YORK: US-IndiaBioPharma & Healthcare Summit 2010 organized by the USA-India Chamber of Commerce in Boston recently attracted..... IndiaPost» View Pdf
Summit to attract leading US-India healthcare firms
NEW YORK: The USA-India Chamber of Commerce (USAIC), a bilateral Chamber of Commerce aimed at promoting and facilitating trade and investment between the United States and India, will organize its annual US-India.... IndiaPost» View Pdf
Greater R&D Collaboration Theme of US-India Biopharma Summit
BOSTON, Mass. — The recent U.S.-India BioPharma & Healthcare
Summit 2010, organized by the USA-India Chamber of Commerce here, attracted over 350 senior
biopharma executives, investors and academic leaders, becoming
one of the leading biopharma events for senior R&D executives.... IndiaWest» View Pdf
2009
US-Indian Chamber of Commerce hails Budget as fiscal stimulus
The USA-India Chamber of Commerce has said the Annual Budget presented by the Finance Minister Pranab Mukherjee is a massive piece of fiscal stimulus which would spur growth and employment... Business Standard » View Pdf Deccan Herald » View Pdf The Hindu » View Pdf Hindustan Times » View Pdf News X » View Pdf The Times of India » View Pdf Zee TV » View Pdf
US-India BioPharma & Healthcare Summit - Media Coverage
India's dearth of Drug R&D Investment Creates Innovation Bottleneck
BOSTON - India faces a lacuna in research and development funding, with lags in government investment and venture capital activity that are creating roadblocks to accelerating the country's growth in pharmaceutical sector, experts said... PharmAsia News» View Pdf
UICC honors Dr. Barry Bloom for distinguished service
NEW YORK: Dr. Barry Bloom, a medical education pioneer in India, was presented with Distinguished Services Award by the USA-India Chamber of Commerce for his longstanding and deep commitment to help improve public health and biomedical science in India; his scientific contributions to immunology, leprosy and tuberculosis; and his passion for educating the next generation of Indian scientists and scholars... IndiaPost» View Pdf
India Chamber felicitates Doctor Barry Bloom
Bostom, August 25 - The USA-India Chamber of Commerce has felicitated Dr Barry Bloom of Harvard...... Emphasising the need for a stronger interface between the industry, academia and NGO, Bloom said the US can learn a great deal from public private partnerships in India... Itv News» View Pdf
USA India Chamber felicitates Doctor Barry Bloom
The USA-India Chamber of Commerce has felicitated Dr Barry Bloom of Harvard...... Felicitating Bloom, Rishi said he has four decades of selfless service to improve public health and medical education in India. Bloom's involvement with India goes back to 1969 when he first visited India... rediff Business» View Pdf
USA India Chamber felicitates Doctor Barry Bloom
Boston, Aug 25 (PTI) The USA-India Chamber of Commerce has felicitated Dr Barry Bloom of Harvard...... the most impressive thing in India is its incredible creative range of public private partnerships. "Whether it is high quality high throughput model where paying patient on one side and poor patient on the other side get the best possible care at hospitals... Yahoo News» View Pdf
Top industry leaders and key policy makers to participate in the US-India BioPharma & Healthcare Summit
US-India BioPharma and Healthcare Summit, an annual summit organized by the USA-India Chamber of Commerce which brings together all stakeholders of the sector to facilitate trade and investments in US-India corridor, had attracted over 300 senior biotech, pharmaceuticals, medical devices and academic leaders this year......there is too much clinical data available in the world, but the challenge lies in converting that data into knowledge for drug discovery. India with its IT strengths can play a vital role.... BioSpectrum » View Pdf
Top industry leaders and key policy makers to participate in the US-India BioPharma & Healthcare
...the necessity to leverage the global intellectual enterprise takes center stage...This is the time for Indian companies to ramp up their capacity and quality standards... BioSpectrum » View Pdf
USAIC Summit sets stage for 'bold, innovative' partnerships
...As we see the pressure to reduce healthcare costs and find innovative solutions to unmet needs build up, the necessity to leverage the global intellectual enterprise takes centre stage.... Express Pharma » View Pdf
US-India drug discovery, collaborative research partnerships growing despite global slowdown
...USA-India Chamber of Commerce applauded the efforts of Government of India's initiative to make India an innovation hub by 2020 and termed it a bold initiative... Express Pharma » View Pdf
Indian healthcare market to grow despite slowdown: McKinsey
Notwithstanding the current global economic crisis, India's pharmaceutical industry and its health care market are expected to grow rapidly in the next few years... The Economic Times » View Pdf The Hindu » View Pdf Hindustan Times » View Pdf Mint » View Pdf Zeenews » View Pdf The Statesman » View Pdf
India can become a global pharma innovation hub, experts say
India has the potential to emerge as a global innovation hub and the US's collabortion with Indian pharma and health companies will not only help the two countries, but also entire world, eminent experts and industry leaders said... The Economic Times » View Pdf
Bio-pharma summit in Boston on May 14
...We have created an ecosystem where all stake holders meet to share and learn. This unique platform creates mutually beneficial opportunities for the US and Indian industry necessary to take the business to the next level,... The Hindu Business Line » View Pdf
...There is an urgent need for US BioPharma industry to engage Indian academia and for Indian industry to connect with US academic institutions. Participants' mood was very upbeat.... India Post » View Pdf
US-India Healthcare Summit to help alliances
...Top tier life sciences focused venture capitalists, private equity firms and investment bankers have shown great interest in the Summit. Since the last Summit, some venture capitalists have set up India/Asia focused funds... India Post » View Pdf
US-India Biopharma, Healthcare Summit on May 14 at Massachusetts
...The keynote address will be delivered on the theme 'Policy Makers and Industry Leaders' and Discussions will be held with Nobel Laureate Prof. Sydney Altman... Pharmaquest » View Pdf
Healthcare industry beats slowdown
...Released recently at the US India Biopharma and Healthcare Summit, the report said that high growth of the Indian healthcare sector was primarily driven by domestic reasons... The Statesman » View Pdf
Indian healthcare market to grow despite slowdown
...Even as managing cost and margin improvement continue to be a focus, there is increasing pressure for companies to collaborate and potentially seek risky investment... Zeenews » View Pdf
US-India Biotech Summit 2008 - Media Coverage
Better days ahead
The meltdown of the US economy has raised legitimate concerns among the Indian establishment and industry. The US economy is in dire straits. The repercussions are being felt across a wide spectrum of industries, notably in financial, banking, housing, automobiles and retail-the leading growth engines in the past decade.... The Week » View Pdf
Sibal exhorts US industry to invest in India's biopharma R&D offering
Over 350 execs and investors attend USAICC summit... BioSpectrum » View Pdf
Challenge is to develop highest quality drugs at the lowest cost: Kapil Sibal
At USA-India Chamber of Commerce's BioPharma Summit the minister spoke about collaborative initiatives between the two countries... Express News Service » View Pdf
U.S. and Indian Officials Collaborate at BioPharma Summit 2008
"Innovation and funding innovation will get a big boost from this Summit," said Karun Rishi, President of the USA-India Chamber of Commerce. "Collaborative research and strategic alliances will be the key forces driving the business."... Drug Discovery » View Pdf
US-India BioPharma Summit in June "The US-India BioPharma Summit is part of an ongoing dialogue with all the stakeholders including industry, investors, policy makers and academia," said Karun Rishi, President of the USA-India Chamber of Commerce.... BioSpectrum Asia » View Pdf
BioPharma in India: U.S.-India Summit
In his keynote address, Indian Minister of Science and Technology Kapil Sibal talked of an emerging intellectual property regime in India that would not only uphold the interests of indulging pharmaceutical companies but shall also match their investment on a 50:50 basis to build an environment to develop collaborative initiatives to mutual benefits in the field of agriculture, marine and health sciences... Siliconeer » View Pdf
US-India BioPharma Summit in Cambridge
...The result oriented work being done by the USA-India Chamber of Commerce to promote and facilitate biotechnology, pharmaceuticals and healthcare business and investments between the two countries is laudable.Globalization has favored the technology intensive industries in general and the biotech industry in particular... India Post » View Pdf
Global Pharma Leaders attend USIndia BioPharma Summit 2008
...Dr. Surinder Singh, Drug Controller General of India in his keynote address talked about implementation of an advanced "e governance drug regulatory system in India". This electronic system, unique in itself is currently being developed with intense support from the Indian IT sector to suit the Indian context, following closer understanding of the functioning of its equivalent counterparts in the world- WHO, Health Canada and FDA. This digitalized and interactive portal is being seen as a revolutionary change to centralize the regulatory system and running clinical trials in India ensuring transparency and accountability at all levels... NRI Today » View Pdf
US-India BioPharma Summit in Boston
...We are seeing a very high level of interest and participation from across the nation and other countries. It has become the bio pharma event of the world focussed on US-India life sciences and healthcare...... India Abroad » View Pdf
GAVI earmarks $350m to immunize poor children in India
...And trying to strengthen GAVI's commitment to India by encouraging corporate philanthropic funding is Boston-based Karun Rishi, President of the USA-India Chamber of Commerce (USAICC), and a 'Friend' of GAVI Alliance... indiapost.com » View Pdf Go back to US India BioTech Summit 2007
US-India Biotech Summit 2007 - Media Coverage
Industry leaders, policy makers bullish about US-India biotech opportunities
The US-India Biotech Summit in Boston attracted over 300 senior executives to discuss and recommend suggestions to take the life sciences business to the next level... BioSpectrum » View Pdf
Research-friendly climate necessary for growth in biotech: experts
Venture capitalists are now not aggressively pursuing deals in India in the biotech space, although this is expected to change in the near future... Mint » View Pdf
Biotech meet aims to double US-India business in 2 years Express News Service » View Pdf
US, India biotech leaders to hold summit at Boston
A galaxy of leaders from the US biotech industry and venture capital segment will interact with the Indian biotech delegation at BIO Boston. The USA-India Chamber of Commerce has put together an exciting evening to bring face-to-face the industry leaders to take the Destination India story in biotech forward... BioSpectrum » View Pdf
US-India Biotech Summit in Boston
The focussed areas of the summit will be discovery, development, IP and regulatory issues, Investment opportunities and mergers and acquisitions of trends in the Life Sciences industry... Mint » View Pdf
